[go: up one dir, main page]

DK1368021T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom - Google Patents

Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom

Info

Publication number
DK1368021T3
DK1368021T3 DK02707850T DK02707850T DK1368021T3 DK 1368021 T3 DK1368021 T3 DK 1368021T3 DK 02707850 T DK02707850 T DK 02707850T DK 02707850 T DK02707850 T DK 02707850T DK 1368021 T3 DK1368021 T3 DK 1368021T3
Authority
DK
Denmark
Prior art keywords
sub
bipolar disorder
phenyl
alkyl
group
Prior art date
Application number
DK02707850T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1368021T3 publication Critical patent/DK1368021T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02707850T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom DK1368021T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
PCT/US2002/005425 WO2002067924A1 (fr) 2001-02-27 2002-02-21 Composes de carbamate utiles pour prevenir ou traiter un trouble bipolaire
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
DK1368021T3 true DK1368021T3 (da) 2008-02-11

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02707850T DK1368021T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom

Country Status (25)

Country Link
US (1) US7122576B2 (fr)
EP (1) EP1368021B1 (fr)
JP (1) JP4276839B2 (fr)
KR (1) KR20030074849A (fr)
CN (1) CN1250214C (fr)
AT (1) ATE378046T1 (fr)
AU (1) AU2002242226B2 (fr)
BR (1) BR0207832A (fr)
CA (1) CA2439292A1 (fr)
CY (1) CY1107199T1 (fr)
CZ (1) CZ296641B6 (fr)
DE (1) DE60223506T2 (fr)
DK (1) DK1368021T3 (fr)
ES (1) ES2295320T3 (fr)
HU (1) HUP0303261A3 (fr)
IL (2) IL157589A0 (fr)
MX (1) MXPA03007716A (fr)
MY (1) MY133370A (fr)
NO (1) NO20033799L (fr)
NZ (1) NZ527989A (fr)
PL (1) PL364640A1 (fr)
PT (1) PT1368021E (fr)
RS (1) RS50680B (fr)
RU (1) RU2286147C2 (fr)
WO (1) WO2002067924A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033947A2 (fr) * 2004-09-16 2006-03-30 Janssen Pharmaceutica, N.V. Techniques de traitement de l'epileptogenese et de l'epilepsie
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0520451A2 (pt) * 2005-07-26 2009-05-12 Janssen Pharmaceutica Nv métodos para tratamento de distúrbios associados a substáncias quìmicas
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
CN102014909B (zh) * 2008-02-21 2013-03-13 田边三菱制药株式会社 口服用固体制剂
NZ590852A (en) 2008-07-16 2013-03-28 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands trans-1{ 4-[2-[4-(2,3-dichlorophenyl)-piperizin-1-yl]-ethyl]-cyclohexyl} -3,3-dimethyl-urea also known as cariprazine
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
CN110290788A (zh) * 2016-12-14 2019-09-27 爱思开生物制药株式会社 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
YU68003A (sh) 2006-08-17
BR0207832A (pt) 2004-06-22
WO2002067924A1 (fr) 2002-09-06
HUP0303261A3 (en) 2012-07-30
EP1368021B1 (fr) 2007-11-14
JP4276839B2 (ja) 2009-06-10
EP1368021A1 (fr) 2003-12-10
MXPA03007716A (es) 2004-11-12
PT1368021E (pt) 2007-12-19
IL157589A0 (en) 2004-03-28
MY133370A (en) 2007-11-30
CN1250214C (zh) 2006-04-12
ES2295320T3 (es) 2008-04-16
NO20033799L (no) 2003-09-10
HUP0303261A2 (hu) 2004-01-28
HK1058762A1 (en) 2004-06-04
RU2003128996A (ru) 2005-03-10
PL364640A1 (en) 2004-12-13
AU2002242226B2 (en) 2006-06-29
US7122576B2 (en) 2006-10-17
RS50680B (sr) 2010-06-30
NZ527989A (en) 2005-12-23
DE60223506T2 (de) 2008-09-18
KR20030074849A (ko) 2003-09-19
CZ20032312A3 (cs) 2004-06-16
CN1503666A (zh) 2004-06-09
DE60223506D1 (de) 2007-12-27
JP2004525905A (ja) 2004-08-26
RU2286147C2 (ru) 2006-10-27
US20020193433A1 (en) 2002-12-19
IL157589A (en) 2009-09-22
CA2439292A1 (fr) 2002-09-06
ATE378046T1 (de) 2007-11-15
NO20033799D0 (no) 2003-08-26
CZ296641B6 (cs) 2006-05-17
CY1107199T1 (el) 2012-11-21

Similar Documents

Publication Publication Date Title
DK1368021T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
MY157373A (en) Carbamate compounds for use in preventing or treating movement disorders
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1305082T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
RU2003128983A (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
DK1408954T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte
WO2003007936A8 (fr) Composes de carbamate destine a etre utilises dans la prevention ou le traitement de la douleur neuropathique et de la douleur associee a la cephalee vasculaire de horton et a la migraine
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain